Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease.
Chang-Hai LiuShanshan ZhengShisheng WangDongbo WuWei JiangQingmin ZengYi WeiYong ZhangHong TangPublished in: Diagnostics (Basel, Switzerland) (2022)
Ceruloplasmin and ORM1 are potential biomarkers in distinguishing mild and severe steatosis in MAFLD patients.